Sisi He

986 total citations · 1 hit paper
37 papers, 685 citations indexed

About

Sisi He is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Sisi He has authored 37 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Sisi He's work include Inflammatory Biomarkers in Disease Prognosis (6 papers), Cholesterol and Lipid Metabolism (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Sisi He is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (6 papers), Cholesterol and Lipid Metabolism (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Sisi He collaborates with scholars based in China, United States and Germany. Sisi He's co-authors include Erik R. Nelson, Amy E. Baek, Michael D. Gunn, Sanghoon Kwon, Ching‐yi Chang, Jongsook Kim Kemper, Hannah McDowell, J. Will Thompson, Patrick M. Sullivan and Donald P. McDonnell and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sisi He

30 papers receiving 682 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells

2017 298 citations Sisi He, Erik R. Nelson et al. profile →

Peers

Countries citing papers authored by Sisi He

Since Specialization

Citations

This map shows the geographic impact of Sisi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sisi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sisi He more than expected).

Fields of papers citing papers by Sisi He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sisi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sisi He. The network helps show where Sisi He may publish in the future.

Co-authorship network of co-authors of Sisi He

This figure shows the co-authorship network connecting the top 25 collaborators of Sisi He. A scholar is included among the top collaborators of Sisi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sisi He. Sisi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ploidy status analysis in small cell lung cancer cells and its use in cytopathological diagnosis 2025 ·International Journal of Clinical and Experimental Pathology ·Sisi He	0
2	Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm, Multi-Centre Phase II Clinical Study 2025 ·Technology in Cancer Research & Treatment ·(unknown), (unknown), Sisi He, Shixiang Wang, Jie Peng, (unknown), Yi Li, Yong Hu, (unknown), (unknown), Hu Ma, Jian‐Guo Zhou	0
3	Optimizing Plant Alkaloid Biosynthesis under Drought Stress: Regulatory Mechanisms and Biotechnological Strategies 2025 ·Journal of Plant Physiology ·Ziyi Guo, Sisi He, Xichun Zhong, Ning Yang, Delin Xu	1
4	Regulatory mechanisms underlying stress-induced accumulation of plant secondary metabolites 2025 ·Journal of Applied Research on Medicinal and Aromatic Plants ·Sisi He, (unknown), Ning Yang, Hongwei Li, (unknown), Lin Li, Weie Wen, Tingting Luo, (unknown), Delin Xu	0
5	Preparation of Sodium Alginate Hydrogels with Bioadhesive and Photothermal Effects to Suppress Bacterial Infection and Promote Wound Healing 2025 ·ACS Applied Materials & Interfaces ·Xueyan Hou, (unknown), Tianmin Xu, Yuxin Wang, Yanxia Hou, (unknown), Yang Su, Shilong Lv, (unknown), (unknown), Sisi He, Yongli Shi	2
6	Polyunsaturated fatty acids, APOE genotypes, and dementia incidence and mortality among hypertensive adults 2025 ·The Journal of Prevention of Alzheimer s Disease ·Yubo Zhang, (unknown), Shaohui Liu, (unknown), (unknown), Sisi He, Yadong Wei, Yunfeng Zou, (unknown), Lijun Wang, Hao Chen	1
7	A prospective cohort study on prognostic implications of serum platelet derived microparticles levels in acute cerebral infarction 2025 ·Scientific Reports ·Sisi He, Xiangdong Huang, (unknown), (unknown), Xin Chen, (unknown), (unknown)	1
8	LncRNA MALAT-1 modulates EGFR-TKI resistance in lung adenocarcinoma cells by downregulating miR-125 2024 ·Discover Oncology ·(unknown), (unknown), Xiaoxi Liu, Qian Zheng, Ling Yang, (unknown), (unknown), Sisi He	4
9	Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy 2024 ·SHILAP Revista de lepidopterología ·Jian‐Guo Zhou, Jie Yang, Haitao Wang, Ada Hang‐Heng Wong, (unknown), Xiaofei Chen, Sisi He, (unknown), Yunjia Wang, Benjamin Frey, Rainer Fietkau, Markus Hecht, Wen‐Zhao Zhong, (unknown), Udo S. Gaipl	1
10	A sodium alginate-based injectable hydrogel system for locoregional treatment of colorectal cancer by eliciting pyroptosis and apoptosis 2024 ·International Journal of Biological Macromolecules ·Yongli Shi, Jingya Zhao, (unknown), (unknown), Yuxin Wang, (unknown), Zeyu Sun, Sisi He, Xueyan Hou	4
11	Differentiation of Cis/trans-geometrical isomers in long-chain unsaturated fatty acids based on ion mobility and theoretical calculations 2024 ·Food Chemistry ·Sisi He, Lulu Shi, (unknown), Fangling Wu, Chuan‐Fan Ding	0
12	Discrimination of 3-aminopyrrolidine derivatives with chiral and positional isomerism through mobility disparity based on non-covalent interactions 2023 ·Microchemical Journal ·Sisi He, (unknown), Chaoxian Chi, Dongdong Zhou, Chuan‐Fan Ding, Xucong Lin, (unknown), Fangling Wu	1
13	A novel self-assembled nanoplatform based on retrofitting poloxamer 188 for triple-negative breast cancer targeting treatment 2023 ·Chemico-Biological Interactions ·Xueyan Hou, (unknown), Sisi He, (unknown), (unknown), Jingjing Xu, Jingwen Wang, (unknown), (unknown), Yanyan Yin, (unknown), Yongli Shi	3
14	Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods 2022 ·Frontiers in Immunology ·Jian‐Guo Zhou, Ada Hang‐Heng Wong, Haitao Wang, (unknown), Xiaofei Chen, Su‐Han Jin, Sisi He, Gang Shen, Yunjia Wang, Benjamin Frey, Rainer Fietkau, Markus Hecht, Hu Ma, Udo S. Gaipl	12
15	Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy 2021 ·Cells ·Jian‐Guo Zhou, Bo Liang, Jianguo Liu, Su‐Han Jin, Sisi He, Benjamin Frey, Ning Gu, Rainer Fietkau, Markus Hecht, Hu Ma, Udo S. Gaipl	31
16	Expression and Clinical Significance of CMTM6 in Nonsmall Cell Lung Cancer 2020 ·DNA and Cell Biology ·Xueyan Hou, Sisi He, Daquan Zhang, Chengli Yang, Yongli Shi, (unknown)	9
17	P2.11-15 Detection of Circulating Genetically Abnormal Cells Improves the Diagnostic Accuracy in Lung Cancer Presenting with GGNs 2019 ·Journal of Thoracic Oncology ·(unknown), Sisi He, (unknown), (unknown), (unknown), Meng Huang, Dongsheng Yue, Chen Huang, (unknown), Xin Yu, (unknown), C. Wang	1
18	Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response 2016 ·Oncotarget ·(unknown), Neal Andruska, (unknown), Sisi He, Amadeo M. Parissenti, Paul J. Hergenrother, Erik R. Nelson, David J. Shapiro	24
19	HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model 2015 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Tao Yin, Sisi He, Guobo Shen, Yongsheng Wang	28
20	Antiangiogenic Therapy Using Sunitinib Combined with Rapamycin Retards Tumor Growth But Promotes Metastasis 2014 ·Translational Oncology ·Tao Yin, Sisi He, Tinghong Ye, Guobo Shen, Yang Wan, Yongsheng Wang	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact